CARE Pharma Shanghai Ltd.
3 clinical trials · Sponsor
◉ Watch CARE Pharma Shanghai Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study on the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CAN106 in Subjects With PNH (NCT05539248) | CARE Pharma Shanghai Ltd. | 2022-03-25 |
| Natural History Study of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis in China (NCT05125341) | CARE Pharma Shanghai Ltd. | 2021-11-25 |
| Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Ascending Dose (SAD) of CAN106 Administered Intravenously (IV) in Healthy Subjects (NCT05095168) | CARE Pharma Shanghai Ltd. | 2021-02-22 |
Track CARE Pharma Shanghai Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.